---
url: "https://www.lek.com/leadership/aditya-natarajan"
title: "Aditya Natarajan | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/aditya-natarajan#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Aditya Natarajan

Aditya Natarajan is a Managing Director and Partner in L.E.K. Consulting’s San Francisco office and a member of the Life Sciences practice. Since joining the firm in 2015, Aditya has led engagements across most therapeutic areas in the pharma, diagnostics and research tools space. With a focus in oncology, he advises both large and emerging biopharma clients on critical strategic and operational issues, including product and franchise strategy, portfolio optimization, M&A, and commercial planning.

Aditya holds a Ph.D. in biochemistry from Stanford University and a B.Sc. in biochemistry and mathematics from Queen’s University.

### Education

**Undergraduate:** Bachelor of Science in Biochemistry and Mathematics, Queen's University

**Graduate:** Ph.D. in Biochemistry, Stanford University

![Aditya Natarajan](https://www.lek.com/sites/default/files/profile-images/aditya-natarajan-web.jpg)

### Aditya's Expertise

#### Industries

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[Diagnostics, Research Tools and Personalized Medicine](https://www.lek.com/industries/life-sciences-pharma/diagnostics-tools-personalized-medicine)

#### Capabilities

[Go-to-Market and Commercial Organization](https://www.lek.com/capabilities/marketing-and-sales/go-to-market-strategy)

[Mergers & Acquisitions](https://www.lek.com/capabilities/mergers-acquisitions)

[Business Unit Strategy](https://www.lek.com/capabilities/strategy/business-unit-strategy)

[Corporate Strategy](https://www.lek.com/capabilities/strategy/corporate-strategy)

Read more

### Related Insights

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies**\\
\\
April 17, 2025](https://www.lek.com/insights/hea/us/ei/launching-novel-cdx-oncology-7-strategies-biopharma-companies)

[Executive Insights\\
\\
\\
**Biotech and Pharmaceuticals****Biopharma Operational Scale-up for First Product Launch: 7 Hazards to Avoid**\\
\\
May 29, 2019\\
\\
Scaling up to launch the first product is one of the most challenging transitions for a biopharma organization as the leadership team prepares to grow an…](https://www.lek.com/insights/ei/biopharma-operational-scale-up)

[Published Articles\\
\\
\\
**Life Sciences & Pharma****Scaling Up for First Product Launch: Seven Hazards to Avoid**\\
\\
April 19, 2019\\
\\
As the margin for error in the drug launch cycle continues to erode, emerging biopharma companies face a growing urgency to double down on scaling up for…](https://www.lek.com/sites/default/files/insights/pdf-attachments/Operational-Scale-up.pdf)

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×